Resistance and phylogenetic analysis in HCV-2c infected patients within the Italian network VIRONET-C
Velia Chiara Di Maio(University of Rome Tor Vergata), Angelico Mario, Miriam Lichtner(Sapienza University of Rome), Luca Carioti(University of Rome Tor Vergata), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Adriano Pellicelli(Carlo Forlanini Hospital), Anna Licata(University of Palermo), Elisabetta Teti(University of Rome Tor Vergata), Roberto Gulminetti(University of Pavia), C. Paternoster, Laura Ambra Nicolini(Ospedale Policlinico San Martino), Loredana Sarmati(University of Rome Tor Vergata), Bianca Bruzzone(Ospedale Policlinico San Martino), Simona Landonio(ASST Fatebenefratelli Sacco), Claudio Maria Mastroianni(Sapienza University of Rome), M. Aragri(University of Rome Tor Vergata), C. Pasquazzi(Azienda Ospedaliera Sant'Andrea), Sergio Babudieri(University of Sassari), Francesco Di Lorenzo(Fondazione Santa Lucia), Ada Bertoli(IRCCS Policlinico San Donato), Laura Monno(University of Bari Aldo Moro), Hamid Hasson(Vita-Salute San Raffaele University), Lavinia Fabeni, Vincenzo Sangiovanni(Ospedale Sant'Anna), Gloria Taliani(Sapienza University of Rome), Teresa Pollicino(University of Messina), Giovanni Raimondo(University of Messina), Mariano Quartini, Nicola Coppola(University of Campania "Luigi Vanvitelli"), A Pieri(Azienda USL di Pescara), Leonardo Baiocchi(Policlinico Tor Vergata), Pietro Andreoné, Giustino Parruti(Azienda USL di Pescara), Valeria Micheli(ASST Fatebenefratelli Sacco), Stefano Novati(Policlinico San Matteo Fondazione), Maria Paola Callegaro, Raffaele Cozzolongo, Katia Yu La Rosa(University of Rome Tor Vergata), Carmine Minichini(University of Campania "Luigi Vanvitelli"), N. Iapadre(San Salvatore Hospital), Silvia Barbaliscia(University of Rome Tor Vergata), Barbara Rossetti, Martina Milana(University of Rome Tor Vergata), Stefania Paolucci(Policlinico San Matteo Fondazione), Simona Marenco, Enzo Boeri(National Cancer Institute), Filomena Morisco, Valeria Pace Palitti(Azienda USL di Pescara), Maurizio Zazzi(University of Siena)
Cited by 0
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection
|American Journal of Transplantation|2016|631
Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2001|470